Clinical Trial Update: T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating T-cell depleted donor lymphocyte infusion for acute myeloid leukemia and high-risk myelodysplastic syndromes; current status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Donor Lymphocyte Infusion (DLI) (Donor Lymphocyte Infusion)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: UNKNOWN